DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20183467

Connection between Dupuytern’s contracture and plantar aponeurosis

Malik Almohideb, Dhaifallah Alziady, Hazem Alotaibi, Fareed Alshehri, Malak Alsaif, Hamad Alkhunayfir, Abdulaziz Aljohani, Talal Alrawaf, Abdulrahman Shata, Mohammed Alghamdi

Abstract


Dupuytren’s disease of the foot is not an uncommon disease that affects the plantar aponeurosis. It is a different clinical entity from Dupuytren’s contracture of hands. It presents clinically with slowly growing painless hard nodules on the medial aspects on the feet. Though the pathophysiological mechanisms remain elusive, hyperproliferation of fibroblasts and excessive synthesis of collagen fibers type III are proposed to be the main pathogenetic processes resulting in nodule development and growing. The most widely accepted theory for disease development is the combination of genetic predisposition and environmental risk factors such as smoking chronic alcohol consumption, diabetes mellitus, and other forms of superficial or dee fibromatosis. This article will discuss the dupuytren’s disease of the foot as regards the epidemiology, the pathophysiology, the clinical presentation, diagnosis, and lines of treatment. It will provide a special focus on the mechanisms of affection of plantar aponeurosis.


Keywords


Dupuytern's contracture, Ledderhose disease, Plantar aponeurosis

Full Text:

PDF

References


Cabeza MR, Leis V, Silvente C, Mauleón C, Suárez R, Lázaro P. Palmo-plantar fibromatosis. Med Cutan Ibero Lat Am. 2007;35(6):298-301.

Haedicke GJ, Sturim HS. Plantar fibromatosis: An isolated disease. Plast Reconstr Surg. 1989;83(2):296-300.

Espert M, Anderson MR, Baumhauer JF. Current Concepts Review: Plantar Fibromatosis. Foot Ankle Int. 2018;39(6):751-7.

Cheung K, Walley KC, Rozental TD. Management of complications of dupuytren contracture. Hand Clin. 2015;31(2):345-4.

Veith NT, Tschernig T, Histing T, Madry H. Plantar Fibromatosis—Topical Review. Foot Ankle Int. 2013;34(12):1742-6.

De Souza, DF, Micaelo L, Cuzzi T, Ramos-e-Silva M. Ledderhose disease. J Clin Aesthet Dermatol. 2010;3(9):45.

Akdag O, Yildiran G, Karamese M, Tosun Z. Dupuytren-Like Contracture of the Foot: Ledderhose Disease. Surg J. 2016;02(03):102-4.

Valdés Tascón F, Caparrini Escondrillas A, Calzada González JM. Fibromatosis plantar. Plantar fibromatosis. 2011;39(4):190-2.

Fausto de Souza D, Micaelo L, Cuzzi T, Ramos-E-Silva M. Ledderhose disease: an unusual presentation. J Clin Aesthet Dermatol. 2010;3(9):45-7.

Pickren JW, Smith AG, Stevenson TW, Stout AP. Fibromatosis of the plantar fascia. Cancer. 1951;4(4):846-56.

De Bree E, Zoetmulder FAN, Keus RB, Peterse HL, Van Coevorden F. Incidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy. Am J Surg. 2004;187(1):33-8.

Von Campe A, Mende K, Omaren H, Meuli-Simmen C. Painful nodules and cords in Dupuytren disease. J Hand Surg Am. 2012;37(7):1313-8.

Gudmundsson KG, Jónsson T, Arngrímsson R. Association of morbus ledderhose with dupuytren’s contracture. Foot Ankle Int. 2013;34(6):841-5.

Pedersen HE, Day AJ. Dupuytren’s disease of the foot. J Am Med Assoc. 1954;154(1):33-5.

Rizzo M. Dupuytren’s Contracture: A Clinical Casebook.; 2016.

Omor Y, Dhaene B, Grijseels S, Alard S. Ledderhose Disease: Clinical, Radiological (Ultrasound and MRI), and Anatomopathological Findings. Case Rep Orthop. 2015;2015:1-3.

Runkel N, Gohring U, Friedl W, Roeren T. Isolated Ledderhose fibromatosis plantaris. Chirurg. 1993;64(7):589-91.

Van Der Veer WM, Hamburg SM, De Gast A, Niessen FB. Recurrence of plantar fibromatosis after plantar fasciectomy: Single-center long-term results. Plast Reconstr Surg. 2008;122(2):486-91.

Dürr HR, Krödel A, Trouillier H, Lienemann A, Refior HJ. Fibromatosis of the plantar fascia: Diagnosis and indications for surgical treatment. Foot Ankle Int. 1999;20(1):13-7.

Al-Qattan MM. Factors in the Pathogenesis of Dupuytren’s Contracture. J Hand Surg Am. 2006;31(9):1527-34.

Kopp J, Seyhan H, Müller B, Lanczak J, Pausch E, Gressner AM, et al. N-acetyl-L-cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren’s disease by blunting TGF-β signalling. J Cell Mol Med. 2006;10(1):157-65.

Fitzgerald A, Kirkpatrick J, Naylor I. Dupuytren’s Disease. The Way Forward? J Hand Surg. 1999;24(4):395-9.

MacCallum SP, Hueston JT. The pathology of dupuytren’s contracture. Aust N Z J Surg. 1962;31(4):241-53.

Matsuzawa I, Shirai Y, Kuriyama N. Contracture of the toes in Dupuytren’s disease. Foot. 1996;6(2):94-6.

Hindocha S, John S, Stanley JK, Watson SJ, Bayat A. The heritability of Dupuytren’s disease: Familial aggregation and its clinical significance. J Hand Surg Am. 2006;31(2):204-10.

Lee LC, Zhang AY, Chong AK, Pham H, Longaker MT, Chang J. Expression of a novel gene, MafB, in Dupuytren’s disease. J Hand Surg Am. 2006;31(2):211-8.

Bayat A, Walter J, Lambe H, et al. Identification of a novel mitochondrial mutation in Dupuytren’s disease using multiplex DHPLC. Plast Reconstr Surg. 2005;115(1):134-41.

Hu FZ, Nystrom A, Ahmed A, et al. Mapping of an autosomal dominant gene for Dupuytren’s contracture to chromosome 16q in a Swedish family. Clin Genet. 2005;68(5):424-9.

Dal Cin P, De Smet L, Sciot R, Van Damme B, Van den Berghe H. Trisomy 7 and trisomy 8 in dividing and non-dividing tumor cells in Dupuytren’s disease. Cancer Genet Cytogenet. 1999;108(2):137-40.

Nikolic J, Janjic Z, Momcilovic D, Ninkovic S, Harhai V. Plantar fibromatosis and Dupuytren’s contracture in an adolescent. Vojnosanit Pregl. 2011;68(10):886-90.